Rep. Miller, Colleagues Re-Introduce the MADE in America Act
April 27, 2023
April 27, 2023
WASHINGTON, April 27 -- Rep. Carol Miller, R-West Virginia, issued the following news release:
Congresswoman Carol Miller (R-WV) reintroduced the Manufacturing API, Drugs, and Excipients (MADE) in America Act to prevent U.S. pharmaceutical supply chain dependence on China and other foreign adversaries. The MADE in America Act will stimulate domestic manufacturing of drugs and pharmaceutical supplies such as active pharmaceutical ingredients (API) and personal protective equipment (P . . .
Congresswoman Carol Miller (R-WV) reintroduced the Manufacturing API, Drugs, and Excipients (MADE) in America Act to prevent U.S. pharmaceutical supply chain dependence on China and other foreign adversaries. The MADE in America Act will stimulate domestic manufacturing of drugs and pharmaceutical supplies such as active pharmaceutical ingredients (API) and personal protective equipment (P . . .